BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28891044)

  • 21. The compliance score as a regressor in randomized trials.
    Joffe MM; Ten Have TR; Brensinger C
    Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intention-to-treat analysis in RCTs.
    El-Masri MM
    Can Nurse; 2015 Apr; 111(3):9. PubMed ID: 25975038
    [No Abstract]   [Full Text] [Related]  

  • 23. Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials.
    Little R; Kang S
    Stat Med; 2015 Jul; 34(16):2381-90. PubMed ID: 25363683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimands in clinical trials - broadening the perspective.
    Akacha M; Bretz F; Ruberg S
    Stat Med; 2017 Jan; 36(1):5-19. PubMed ID: 27435045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trials which randomize practices I: how should they be analysed?
    Kerry SM; Bland JM
    Fam Pract; 1998 Feb; 15(1):80-3. PubMed ID: 9527302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choice of estimand and analysis methods in diabetes trials with rescue medication.
    Holzhauer B; Akacha M; Bermann G
    Pharm Stat; 2015; 14(6):433-47. PubMed ID: 26337856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy.
    Welsh AW
    BMC Pregnancy Childbirth; 2013 Jan; 13():15. PubMed ID: 23324442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs.
    Antman EM
    Circulation; 2017 May; 135(21):2062-2072. PubMed ID: 28533319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critically appraising noninferiority randomized controlled trials: a primer for emergency physicians.
    Al Deeb M; Azad A; Barbic D
    CJEM; 2015 May; 17(3):231-6. PubMed ID: 26034906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observational epidemiology within randomized clinical trials: getting a lot for (almost) nothing.
    Howard G; Howard VJ
    Prog Cardiovasc Dis; 2012; 54(4):367-71. PubMed ID: 22226006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response studies. I. Some design considerations.
    Ruberg SJ
    J Biopharm Stat; 1995 Mar; 5(1):1-14. PubMed ID: 7613556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the randomized controlled trial in plastic surgery.
    Thoma A; Sprague S; Temple C; Archibald S
    Clin Plast Surg; 2008 Apr; 35(2):275-84. PubMed ID: 18298999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of covariate imbalance on the size of the logrank test in randomized clinical trials by N. Kinukawa, T. Nakamura, K. Akazawa and Y. Nose, Statistics in Medicine 2000; 19: 1955-1967.
    Mazumdar M
    Stat Med; 2002 Apr; 21(8):1167; author reply 1167-71. PubMed ID: 11933040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.